DAX-0,49 % EUR/USD+0,03 % Gold0,00 % Öl (Brent)-0,10 %

AgeX TherapeuticsAktie

ISIN: US00848H1086 | WKN: A2N8PC | Symbol: AGE
1,480
 
USD
18:53:43 AMEX
+17,46 %
+0,220 USD
Geldkurs 18:53:43
1,480 USD
100 Stk.
Briefkurs 18:53:43
1,520 USD
100 Stk.
Mehr Daten anzeigen
NewsFlashAnzeige
Hammernews - jetzt ist es raus - renommierte Minen-Experten engagieren sich bei U.S. Gold!

AgeX Therapeutics Chart

Neuigkeiten zur AgeX Therapeutics Inc Aktie

ZeitTitel
13:00 Uhr

AgeX Therapeutics Issues Year-End Letter to Shareholders
14.11.19

AgeX Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
09.11.19

AgeX Therapeutics to Present at Investing in the Age of Longevity Conference
30.10.19

AgeX Therapeutics and Juvenescence Publish Paper on Engineering Strategies for Universal Cells and Provide in Vivo Observation on Immunotolerance UniverCyteTM Technology Platform
11.10.19

AgeX Therapeutics to Present at Metabesity 2019
09.09.19

AgeX Therapeutics Presents at the Rodman & Renshaw Global Investment Conference
04.09.19

AgeX Therapeutics Publishes Theoretical Basis of Human Cell Age-Reversal in the Journal Regenerative Medicine
05.08.19

Regenerative Medicine Leader Michael H. May Joins AgeX Board of Directors
01.08.19

Avatar R-BgO schrieb:
Bild: 3595_20190801100927_Bildschirmfoto 2019-08-01 um 10
15.05.19

AgeX Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update
01.05.19

AgeX Therapeutics to Participate at Biotech Investing in Longevity from Aikora Health and Foresight Institute
05.04.19

AgeX Therapeutics to Present at Master Investor Show 2019
01.04.19

AgeX Therapeutics Reports Fourth Quarter and Annual 2018 Financial Results and Provides Business Update
22.03.19

AgeX Therapeutics Receives $4.5 Million From Exercise of Warrants

Insidertrade: :
Hier Upload von Dokumenten / Links zum Wertpapier: Upload

Die neusten Nachrichten zu AgeX Therapeutics

ZeitTitel
13:00 Uhr
AgeX Therapeutics Issues Year-End Letter to Shareholders
14.11.19
AgeX Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
09.11.19
AgeX Therapeutics to Present at Investing in the Age of Longevity Conference
30.10.19
AgeX Therapeutics and Juvenescence Publish Paper on Engineering Strategies for Universal Cells and Provide in Vivo Observation on Immunotolerance UniverCyteTM Technology Platform
11.10.19
AgeX Therapeutics to Present at Metabesity 2019
mehr AgeX Therapeutics Nachrichten »

Nachrichten aus der Branche Biotechnologie

ZeitTitel
18:30 Uhr
DEINOVE and ESPCI Paris obtain funding from the ANR to develop the Deinodrop technology
18:30 Uhr
 DEINOVE and ESPCI Paris Obtain Funding From the ANR to Develop the Deinodrop Technology
18:15 Uhr
BERENBERG belässt MORPHOSYS auf 'Buy'
18:00 Uhr
Quantum Genomics and Biolab Sanus Pharmaceutical Enter into Exclusive Licensing and Collaboration Agreement for Firibastat in Latin America
18:00 Uhr
Transgene Announces Investor Meetings for January 2020
mehr Branchennachrichten »

Diskussionen zur AgeX Therapeutics Aktie

ZeitTitel
01.08.19
2
AgeX Therapeutics

Indexzugehörigkeit von AgeX Therapeutics

WertpapierPerf. %
Russell 2000 (calculated by Bridge Data Services)
0,00
NYSE American Composite Healthcare Subsector Index
+0,08
NYSE American Composite Index
+1,33
Alle zugehörigen Indizes »

Aktienkurs AgeX Therapeutics A2N8PC |

BörsenplatzAMEX
Letzter Kurs1,480USD
Performance+17,46 %
Kurszeit18:53:43
Eröffnung1,260USD
Tageshoch1,570USD
Tagestief1,260USD
Vortageskurs1,260USD
Volumen30,90 Tsd.Stk.
52-Wochen Hoch8,000USD
52-Wochen Tief1,000USD
Anzahl Trades58
Performance 1 Monat-17,76 %
Performance 1 Jahr-75,73 %

Stammdaten zu AgeX Therapeutics

NameAgeX Therapeutics Inc
KurznameAgeX Therapeuti
NamenszusatzRegistered Shs
KategorieAktien
AktientypStammaktien
WKNA2N8PC
SymbolAGE
BrancheBiotechnologie
LandUSA USA
ReferenzwährungUSD
Aktienanzahl37,65 Mio.
Marktkapitalisierung55,72 Mio.USD

Performance AgeX Therapeutics Aktie

ZeitKursPerf.
1 Tag1,480USD
+17,46 %
1 Woche1,420USD
-11,97 %
1 Monat1,520USD
-17,76 %
3 Monate2,600USD
-51,92 %
6 Monate2,800USD
-55,36 %
Lfd. Jahr2,990USD
-58,19 %
1 Jahr5,150USD
-75,73 %
mehr Performancedaten »
Adresse und Kontaktdaten
NameAgeX Therapeutics Inc
StadtAlameda, CA
LandUSA USA
Webseitewww.agexinc.com
Aktionäre interessieren sich auch für:
#WertpapierPerf. %
1.
Takara Bio
0,00
 
2.
United Therapeutics
+1,45
3.
Vertex Pharmaceuticals
+0,06
4.
Amarin
+2,94
5.
Genscript Biotech Corporation
+3,60
6.
Proteostasis Therapeutics
-7,14
7.
Editas Medicine
+1,71
8.
Novavax
-4,41
9.
Lineage Cell Therapeutics
-3,01
10.
Telo Genomics
-12,50

Emissionsinformationen

ZeichnungsgebührNein
PlatzierungÖffentlich